PetMed Express, Inc.
PETS
$3.40
-$0.09-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.72% | -20.37% | -18.39% | -14.51% | -7.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.72% | -20.37% | -18.39% | -14.51% | -7.92% |
| Cost of Revenue | -20.57% | -21.65% | -19.70% | -19.77% | -13.41% |
| Gross Profit | -24.15% | -17.53% | -15.46% | -1.08% | 6.36% |
| SG&A Expenses | 9.70% | 6.54% | -12.90% | -9.47% | 4.15% |
| Depreciation & Amortization | 16.71% | 7.07% | -0.24% | 11.45% | 32.26% |
| Other Operating Expenses | -8.27% | -8.27% | -8.27% | -416.28% | -416.28% |
| Total Operating Expenses | -10.68% | -12.93% | -17.26% | -16.81% | -8.46% |
| Operating Income | -7,287.30% | -4,793.87% | -38.16% | 174.58% | 132.01% |
| Income Before Tax | -9,915.98% | -29,555.64% | 90.64% | 181.84% | -619.15% |
| Income Tax Expenses | 1,193.68% | 93.98% | 377.25% | 380.86% | -49.63% |
| Earnings from Continuing Operations | -5,613.71% | -1,616.28% | 15.98% | 113.40% | -13.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5,613.71% | -1,616.28% | 15.98% | 113.40% | -13.43% |
| EBIT | -7,287.30% | -4,793.87% | -38.16% | 174.58% | 132.01% |
| EBITDA | -395.03% | -277.50% | -220.23% | 316.06% | 54.93% |
| EPS Basic | -5,345.38% | -1,584.66% | 17.19% | 112.40% | -16.51% |
| Normalized Basic EPS | -1,556.79% | -1,061.06% | -81.02% | 332.26% | 59.09% |
| EPS Diluted | -4,368.07% | -1,432.97% | 18.71% | 104.41% | -16.67% |
| Normalized Diluted EPS | -1,665.83% | -1,133.15% | -83.20% | 322.08% | 51.45% |
| Average Basic Shares Outstanding | 1.14% | 1.05% | 0.98% | 0.88% | 0.78% |
| Average Diluted Shares Outstanding | 0.20% | 0.46% | 1.43% | 1.32% | 1.22% |
| Dividend Per Share | -- | -- | -- | -100.00% | -100.00% |
| Payout Ratio | 1.00% | 1.00% | 0.98% | 1.08% | 0.99% |